Journal
JOURNAL OF MEDICINAL CHEMISTRY
Volume 60, Issue 8, Pages 3511-3517Publisher
AMER CHEMICAL SOC
DOI: 10.1021/acs.jmedchem.6b01836
Keywords
-
Categories
Funding
- Janssen Research & Development, LLC.
Ask authors/readers for more resources
A prevalent observation in high-throughput screening and drug discovery programs is the inhibition of protein function by small-molecule compound aggregation. Here, we present-the X-ray structural description of aggregation-based inhibition of a protein protein interaction involving tumor necrosis factor alpha (TNF alpha). An ordered conglomerate of an aggregating small-mUlecule inhibitor (JNJ525) induces a qUaternary structure switch of TNF alpha that inhibits the protein-protein interaction between TNF alpha and TNF alpha receptors. SPD-304 may employ a similar mechanism of inhibition.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available